Implantable drug delivery systems with morphine in fibromyalgia -A case report

• Published in: Anesthesia and pain medicine (Korean society of anesthesiologists) Vol. 12; no. 1; pp. 91 - 94
• Main Authors: Ju, Yu Mi, Shin, Sang Ho, Choi, Shu Chung, Chon, Jin Young, Sung, Choon Ho, Moon, Ho Sik
• Format: Journal Article
• Language: English
• Published: 대한마취통증의학회 31.01.2017
• Subjects: 마취과학
• ISSN: 2383-7977; 1975-5171; 2383-7977
• DOI: 10.17085/apm.2017.12.1.91

The fibromyalgia syndrome (FMS) could be approached by various treatments modalities including education, aerobic exercise, cognitive behavioral therapy, tricyclic antidepressants, serotonin norepinephrine reuptake inhibitors, pregabalin, and so on. If other treatments fail, opioids including morphine should be considered. In this case report, we describe the case of a 44-year-old woman who was diagnosed with FMS three years ago, and suffered from severe intractable pain, side effects from other drugs, and opioid tolerance. Administration of morphine via an implantable drug delivery system resulted in significant improvement in the patient’s pain intensity, fibromyalgia impact questionnaire score, and sleep disturbance. Our case demonstrates that an implantable drug delivery system with morphine can be a potential treatment option for refractory fibromyalgia patients. KCI Citation Count: 0